Skip to main content
. 2017 Jan 24;61(2):e01794-16. doi: 10.1128/AAC.01794-16

FIG 2.

FIG 2

Time to detectable CMV viremia according to study drug group. The proportion of patients without detectable CMV viremia during follow-up according to study group (modified intention-to-treat population) is shown.